Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism

Journal of Hypertension

Volumn 30, Issue 8, 2012, Pages 1606-1613

  Lin, Yen Hung ^a   Wu, Xue Ming ^c   Lee, Hsiu Hao ^d   Lee, Jen Kuang ^e   Liu, Yu Chun ^a,f   Chang, Hung Wei ^a,f   Lin, Chien Yu ^g   Wu, Vin Cent ^a   Chueh, Shih Chieh ^b,h   Lin, Lung Chun ^a   Lo, Men Tzung ⁱ   Ho, Yi Lwun ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^f Far Eastern Polyclinic   (Taiwan)

^g EN CHU KONG HOSPITAL   (Taiwan)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

adrenalectomy; carboxy terminal propeptide of procollagen type I; cyclic variation of integrated backscatter; myocardial fibrosis; primary aldosteronism

Indexed keywords

ALDOSTERONE; POTASSIUM; PROCOLLAGEN C PROTEINASE; RENIN;

ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART MUSCLE FIBROSIS; HUMAN; MALE; PLASMA RENIN ACTIVITY; POSTOPERATIVE PERIOD; POTASSIUM BLOOD LEVEL; PREOPERATIVE PERIOD; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84863838252     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283550f93     Document Type: Article

References (42)

1. Rossi GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep 2010; 12:342-348.
2. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992; 26:671-677.
3. Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35:138-147.
4. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67:1355-1364.
5. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002; 40:23-27.
6. Kozakova M, Buralli S, Palombo C, Bernini G, Moretti A, Favilla S, et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003; 41:230-236.
7. Yoshitomi Y, Nishikimi T, Abe H, Yoshiwara F, Suzuki T, Ashizawa A, et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996; 27:319-323.
8. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50:911-918.
9. Mimbs JW, O'Donnell M, Bauwens D, Miller JW, Sobel BE. The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 1980; 47:49-58.
10. O'Donnell M, Mimbs JW, Miller JG. Relationship between collagen and ultrasonic backscatter in myocardial tissue. J Acoust Soc Am 1981; 69:580-588.
11. Di Bello V, Giorgi D, Talini E, Dell' Omo G, Palagi C, Romano MF, et al. Incremental value of ultrasonic tissue characterization (backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 2003; 107:74-80.
12. Galetta F, Bernini G, Franzoni F, Bacca A, Fivizzani I, Tocchini L, et al. Cardiac remodeling in patients with primary aldosteronism. J Endocrinol Invest 2009; 32:739-745.
13. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104:286-291.
14. Lin YH, Shiau YC, Yen RF, Lin LC, Wu CC, Ho YL, et al. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients. Ultrasound Med Biol 2004; 30:885-891.
15. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38:1222-1226.
16. Maceira AM, Barba J, Varo N, Beloqui O, Diez J. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives. Hypertension 2002; 39:923-928.
17. Lin YH, Ho YL, Wang TD, Liu CP, Kao HL, Chao CL, et al. The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation. Clin Biochem 2006; 39:861-866.
18. Lin YH, Lin C, Lo MT, Lin HJ, Wu YW, Hsu RB, et al. The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death. Clin Chem Lab Med 2010; 48:1821-1827.
19. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales investigators. Circulation 2000; 102:2700-2706.
20. Lin YH, Lin LY, Wu YW, Chien KL, Lee CM, Hsu RB, et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta 2009; 409:96-99.
21. Stehr CB, Mellado R, Ocaranza MP, Carvajal CA, Mosso L, Becerra E, et al. Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens 2010; 28:2120-2126.
22. Lin YH, Lee HH, Liu KL, Lee JK, Shih SR, Chueh SC, et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery 2011; 150:526-533.
23. Kuo CC, Wu VC, Tsai CW, Wu KD. Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011; 12:113-122.
24. Lin YH, Wang SM, Wu VC, Lee JK, Kuo CC, Yen RF, et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur J Clin Invest 2011; 41:743-750.
25. Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta 2011; 412:1319-1325.
26. Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, et al. Diagnosis of primary aldosteronism: comparison of postcaptopril active renin concentration and plasma renin activity. Clin Chim Acta 2010; 411:657-663.
27. Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC, et al. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J Renin Angiotensin Aldosterone Syst 2011; 12:48-53.
28. Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 2011; 12:348-357.
29. Liao CH, Chueh SC, Lai MK, Hsiao PJ, Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab 2006; 91:3080-3083.
30. Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M, et al. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 1992; 112:987-993.
31. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
32. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 2002; 106:1572-1585.
33. Lin YH, Lee HH, Liu KL, Lee JK, Shih SR, Chueh SC, et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery 2011; 150:526-533.
34. Horita Y, Inenaga T, Nakahama H, Ishibashi-Ueda H, Kawano Y, Nakamura S, et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 2001; 37:884-889.
35. Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol 1991; 86 (Suppl 3):25-31.
36. Matsumura K, Fujii K, Oniki H, Oka M, Iida M. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 2006; 19:13-18.
37. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997; 20:85-90.
38. Brilla CG, Matsubara LS, Weber KT. Antialdosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993; 25:563-575.
39. Hall CS, Scott MJ, Lanza GM, Miller JG, Wickline SA. The extracellular matrix is an important source of ultrasound backscatter from myocardium. J Acoust Soc Am 2000; 107:612-619.
40. Holland MR, Wilkenshoff UM, Finch-Johnston AE, Handley SM, Perez JE, Miller JG. Effects of myocardial fiber orientation in echocardiography: quantitative measurements and computer simulation of the regional dependence of backscattered ultrasound in the parasternal short-axis view. J Am Soc Echocardiogr 1998; 11:929-937.
41. Lin LC, Wu CC, Ho YL, Lin CW, Chen WJ, Chen MF, et al. Ultrasonic tissue characterization for coronary care unit patients with acute myocardial infarction. Ultrasound Med Biol 1998; 24:187-196.
42. Gonzalez A, Lopez B, Ravassa S, Beaumont J, Arias T, Hermida N, et al. Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovasc Res 2009; 81:509-518.